Drotrecogin alfa (activated, Serendex Pharmaceuticals)

N/A

Report date: 2022/11/05 17:26:47

Base Information

Drug NameDrotrecogin alfa (activated, Serendex Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPlasminogen modulators
TargetsPlasminogen
Therapy Area/IndicationsRespiratory Distress Syndrome, Newborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesSavara Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesSavara Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Newborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A